Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Akorn Inc. News

Generic-Drug Maker Akorn Files Chapter 11

Generic-drug maker Akorn filed a Chapter 11 petition. A deal with its lenders will enable it to continue a search for a buyer.

Drugmaker Akorn Receives FDA Warning Letter Regarding N.J. Facility

Akorn receives a warning letter from the U.S. Food & Drug Administration regarding an inspection of the company's facility in Somerset, New Jersey.

Dow Loses Steam as Yields Hover Near 3% Threshold

The S&P 500 finished slightly higher, up just 0.01%.

Akorn's Stock Crashes as Germany's Fresenius Ends Takeover Amid Data Allegations

Akorn shares plummeted Monday after Germany's Fresenius Medical ditched its planned $5 billion takeover amid allegations of data misconduct at the Lake Forest, Ill.-based generic drugmaker.

Alphabet Earnings and 4 Other Business Stories You Must Know Monday Morning

Happy Monday! These are the headlines you need to see during your morning commute.

Breaking News

Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll

Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.

Summers, Others Cite Growing Chance of Recession

GDP shrank an annualized 1.6% in the first quarter, and some experts anticipate another drop in the second quarter.

Coinbase Faces A New Scandal

The platform denies selling proprietary customer data and announces it is expanding into several European countries.